| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/11/2006 | WO2005114209A3 Diagnostics and therapeutics for diseases associated with g protein-dependent receptor kinase 2 (grk2) |
| 05/11/2006 | WO2005114107A3 Use of a monoclonal antibody that specifically binds stem cells |
| 05/11/2006 | WO2005107404A3 Methods and systems for nanoparticle enhancement of signals |
| 05/11/2006 | WO2005106471A3 Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 4 (ccr4) |
| 05/11/2006 | WO2005105839A3 Essential tremor diagnostic and treatment |
| 05/11/2006 | WO2005103300A9 Pattern recognition method for diagnosis of systemic autoimmune diseases |
| 05/11/2006 | WO2005099394A3 Methods and devices for microarray image analysis |
| 05/11/2006 | WO2005095459A3 Monoclonal antibodies to gastrin hormone |
| 05/11/2006 | WO2005085849A3 Biohazard identification by fluorescent immunoassay and single molecule detection |
| 05/11/2006 | WO2005080940A8 Identification of blood elements using inverted microscopy |
| 05/11/2006 | WO2005067486A8 Quantitative protein assay using single affinity capture agent for identification and detection |
| 05/11/2006 | WO2005060626A3 Metal ion mediated fluorescence superquenching assays, kits and reagents |
| 05/11/2006 | WO2005056764A3 Inhibitors of type 2 vascular endothelial growth factor receptors |
| 05/11/2006 | WO2005050188A9 Quantification method with the use of isotope-labeled internal standard, analysis system for carrying out the quantification method and program for dismantling the same |
| 05/11/2006 | WO2005024351A3 Real time determination of gas solubility and related parameters in manufacturing processes |
| 05/11/2006 | WO2005010023A3 Method for prediction of an epitope |
| 05/11/2006 | WO2004098384A3 Parallel analysis of molecular interactions |
| 05/11/2006 | WO2004042028A3 Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas |
| 05/11/2006 | WO2004041204A3 Methods and compositions for treating neurodegenerative diseases |
| 05/11/2006 | WO2004034020A3 Hydrodynamic micromanipulation of individual cells to patterned attachement sites |
| 05/11/2006 | WO2003104851A3 Method using a nonlinear optical technoque for detection of interactions involving a conformational change |
| 05/11/2006 | WO2003064991A3 Method and apparatus using a nonlinear optical technique for detection of probe-target interactions in a field |
| 05/11/2006 | WO2002098351A8 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2 |
| 05/11/2006 | WO2002094997A3 Transcriptional regulation of target genes |
| 05/11/2006 | US20060101532 Methods for the identification of compounds for the treatment of Alzheimer's disease |
| 05/11/2006 | US20060101530 Rors as modifiers of the p21 pathway and methods of use |
| 05/11/2006 | US20060101529 Lymphocyte surface receptor that binds CAML and methods of use thereof |
| 05/11/2006 | US20060101528 Transgenic clawed frog embryos and use thereof as detectors of endocrine disrupters in the environment |
| 05/11/2006 | US20060100910 Interactive video based remote health monitoring system |
| 05/11/2006 | US20060100791 Methods, computer software products and systems for clustering genes |
| 05/11/2006 | US20060100420 5-hydroxytryptophol (5-HTOL) derivatives, antibodies, immunoassays and detection of recent alcohol consumption |
| 05/11/2006 | US20060100153 HSulf-1 nucleic acids, polypeptides and methods of using |
| 05/11/2006 | US20060100152 Methods and compositions in treating pain and painful disorders using 9949, 14230, 760, 62553, 12216, 17719, 41897, 47174, 33408, 10002, 16209, 314, 636, 27410, 33260, 619, 15985, 69112, 2158, 224, 615, 44373, 95431, 22245, 2387, 16658, 55054, 16314, 1613, 1675, 9569 or 13424 molecules |
| 05/11/2006 | US20060100132 Method for diagnosing inflammatory bowel disease |
| 05/11/2006 | US20060100131 Modulation of stem cell differentiation by modulation of caspase-3 activity |
| 05/11/2006 | US20060099721 Using functionalized immunoglobulins as components of bioassays which determine concentration of low molecular weight chemicals, such as bioterrorism toxins, shellfish toxins, mycotoxins, aflatoxins and agricultural crop drugs in test volumns; drug delivery agents |
| 05/11/2006 | US20060099720 Methods for performing differential capture proteomics |
| 05/11/2006 | US20060099719 Biochemical assay |
| 05/11/2006 | US20060099715 Electrical measuring instrument connected to a layer of conductive particles of carbon or pigment whose surfaces have been modified by covalent reaction wiith an organic compound; the sensor detects an alteration in the preexisting resistance of the layer in the presence of the analyte |
| 05/11/2006 | US20060099714 Detection and analysis of ophthalmically-relevant fluorescent molecules |
| 05/11/2006 | US20060099713 Targeted-assisted iterative screening (tais):a novel screening format for large molecular repertoires |
| 05/11/2006 | US20060099712 Correlation of anti-cancer activity of dyes with redox potentials |
| 05/11/2006 | US20060099706 Exposure device |
| 05/11/2006 | US20060099703 Device for quantitative analysis of biological materials |
| 05/11/2006 | US20060099688 polypeptides having transferse enzyme activity, used for biosynthesis of polysaccharides; genetic engineering |
| 05/11/2006 | US20060099686 Generation of artificial binding proteins on the basis of ubiquitin proteins |
| 05/11/2006 | US20060099683 Isolated hOAT polypeptide |
| 05/11/2006 | US20060099682 Human vanilloid receptors and their uses |
| 05/11/2006 | US20060099680 Yeast transformant into which genes associated with synthesis system of O-fucosylated protein are introduced |
| 05/11/2006 | US20060099669 High throughput assay system |
| 05/11/2006 | US20060099665 Taxol immunoassay |
| 05/11/2006 | US20060099664 combining a sample and binding partner, adding a reagent with a ligand and an analyte analog, a second reagent with a binding partner for the ligand, the binding alters the amount of signal produced if analytes are present |
| 05/11/2006 | US20060099663 Peptide sequence tags and method of using same |
| 05/11/2006 | US20060099662 Using anti-idiotypic antibody to determine CD20 concentration of cell; screening for modulators for prevention and/or treatment of HIV infection and cancer |
| 05/11/2006 | US20060099661 Detection and quantification of intracellular pathogens |
| 05/11/2006 | US20060099660 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
| 05/11/2006 | US20060099659 Method to detect IgE |
| 05/11/2006 | US20060099658 PCA3, PCA3 genes, and methods of use |
| 05/11/2006 | US20060099657 Wound healing agents; anticancer agents; cardiovascular disorders; detecting expression of a polypeptide in a test sample; lower expression of polypeptide indicates the presence of melanoma |
| 05/11/2006 | US20060099656 Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692, 58874, 252, 304, 1980, 14717, 9941, 1941, 19310, or 17832 |
| 05/11/2006 | US20060099655 Cloning of a human cytoplasmic polyadenylation element binding protein (hCPEB) with sequence-specific RNA binding activity; examining reproductive potential of a oocyte; gene expression |
| 05/11/2006 | US20060099654 Methods and kits for the determination of sirolimus in a sample |
| 05/11/2006 | US20060099653 Microscopic precision construction of tissue array block related application data |
| 05/11/2006 | US20060099652 IL 13 receptor alpha 2 antibody and methods of use |
| 05/11/2006 | US20060099651 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
| 05/11/2006 | US20060099650 Toll-like receptor assays |
| 05/11/2006 | US20060099649 Method and apparatus for assay for multiple analytes |
| 05/11/2006 | US20060099648 Compositions and methods for epitope mapping |
| 05/11/2006 | US20060099647 Separating the components of plasma according to weight on a strip of SDS-polyacrylamide gel, incubating the gel in SDS-PAGE treatment, transferring the gel to a second, larger, SDS-polyacrylaniide gel for electrophoretic separation, and identifying the SDS resistant proteins |
| 05/11/2006 | US20060099646 Bret assay |
| 05/11/2006 | US20060099645 Methods and reagents for assaying molecular interactions |
| 05/11/2006 | US20060099644 Standard for measurement composed of an oxidized LDL/ beta 2-glycoprotein I complex that is not dissociated in the presence of 100 U/ml heparin nor in the presence of 10 mM MgCl2; disease diagnosis |
| 05/11/2006 | US20060099643 Method for determining the regulation of xenobiotic removal |
| 05/11/2006 | US20060099642 Solid-phase substrate for immobilizing biomolecules |
| 05/11/2006 | US20060099640 SLO2 and SLO4, novel potassium channel proteins from human brain |
| 05/11/2006 | US20060099638 incorporating indolium ring moiety substituted at 3-position improves spectral properties; for detection of ligands; hybridization probes |
| 05/11/2006 | US20060099637 Oligonucleotide and method for detecting Verotoxin |
| 05/11/2006 | US20060099635 Anti-GL50 antibodies |
| 05/11/2006 | US20060099634 Simplified biological evaluation method of natural and artificial chemicals by using DNA injury index and apparatus therefor |
| 05/11/2006 | US20060099629 Detecting uropathogenic E. coli genes by testing the strain for the ability to grow in the presence of D-serine; identification of new E. Coli-specified pathogenicity factors may facilitate the development of new methods of treating or preventing urinary tract infections |
| 05/11/2006 | US20060099625 MT-SP1 serine protease |
| 05/11/2006 | US20060099624 System and method for providing personalized healthcare for alzheimer's disease |
| 05/11/2006 | US20060099619 Detection and quantification of miRNA on microarrays |
| 05/11/2006 | US20060099615 Method of detecting target nucleotide sequence, structure and preparation of the detection target used for working the detection method, and assay kit for detecting the target nucleotide sequence |
| 05/11/2006 | US20060099608 Methods of diagnosing cardiovascular disease |
| 05/11/2006 | US20060099604 Cysteamine moiety covalently attached to a phthalein, xanthene or naphthalimide dye or a fluorophore, chromophore, magnetic particle, gold particle, or isotopic mass label to form a target-associative tag for analyzing, identifying, or purifying phosphorylated proteins |
| 05/11/2006 | US20060099601 Novel compositions and processes for analyte detection, quantification and amplification |
| 05/11/2006 | US20060099600 Novel acetylcholine transporter |
| 05/11/2006 | US20060099595 Culturing an Huh-7.5 cell line (ATCC accession number PTA-8561) that also has a genomic or subgenomic HCV RNA capable of replication, curing with an antiviral agent, and identifying sublines that are permissive for HCV replication. |
| 05/11/2006 | US20060099594 Method of predicting genetic risk for hypertension |
| 05/11/2006 | US20060099593 Method of diagnosing integration dysfunction syndrome using blood |
| 05/11/2006 | US20060099591 Diagnosis of chronic rejection |
| 05/11/2006 | US20060099586 Eef1a2 for use in the prognosis, diagnosis, and treatment of cancer |
| 05/11/2006 | US20060099583 Compositions and methods for identifying antiviral agents |
| 05/11/2006 | US20060099582 Determining an index of organ health in the course of transplantation therapy comprising measuring the expression level of peripheral-type benzodiazepine receptor (PBR); predictor of the outcome of transplantation therapy |
| 05/11/2006 | US20060099576 Method for diagnosing a pre-neoplastic or neoplastic lesion in transitional epithelial cells |
| 05/11/2006 | US20060099573 Diagnostic assays |
| 05/11/2006 | US20060099571 Protease and peptidase-resistant proteins; Drug screening for control of cell division, apoptosis; for cancer treatment |
| 05/11/2006 | US20060099570 Device and method for non-invasive measurement of the individual metabolic rate of a substantially spherical metabolizing particle |
| 05/11/2006 | US20060099569 Method and device for diagnosing oncological diseases |